Effects of acupressure on dyspnea and anxiety in patients with chronic obstructive pulmonary disease: A randomized controlled trial
Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
Çiğdem Ergin1, Songül Karadağ2
1Çukurova University, Faculty of Health Sciences, Adana, Türkiye; Ömer Halisdemir Training and Research Hospital, Niğde, Türkiye.
Aim:
This study aimed to evaluate the effects of acupressure on dyspnea and anxiety levels in patients with chronic obstructive pulmonary disease (COPD).
Design And Methods:
A randomized controlled trial was conducted with 60 patients diagnosed with COPD. Acupressure was applied to the LI4, HT7, LU1, and ST36 points in the intervention group. Data were collected using the Modified Borg Scale (MBS), Medical Research Council Dyspnea Scale (MRC), and Beck Anxiety Inventory (BAI). A p-value of <0.05 was considered statistically significant.
Findings:
Acupressure significantly reduced both dyspnoea and anxiety in the intervention group (p < 0.001). A moderate positive correlation was observed between dyspnea and anxiety scores.
Practice Implications:
Acupressure may serve as a nurse-led, non-pharmacological intervention to manage symptoms in patients with COPD. Further studies are recommended to examine its broader clinical utility.
Relevance To Clinical Practice:
Acupressure has the potential to enhance patient comfort and contribute to holistic symptom management in patients with COPD.
Patient Or Public Contribution:
While patients did not participate in the study design, data analysis, or manuscript writing, they actively engaged in the intervention by voluntarily accepting acupressure and consistently applying it at home. Their adherence provided insight into the feasibility of acupressure in real-world settings.
More Related Videos
07:10Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: